Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASM-024 in Mild Allergic Asthma
NCT01092403Phase 2Completed
- Sponsor
- Asmacure Ltée
- Start
- Apr 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of asm-024 in allergic asthma, sponsored by Asmacure Ltée. Started Apr 2010; status: completed.
02
Drugs
asm-024
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT01092403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092403.